These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6876750)

  • 1. Social and personality factors in dapsone resistant patients.
    John JK; Pannikar VK; Verghese A; Christian M
    Lepr India; 1983 Jan; 55(1):100-6. PubMed ID: 6876750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment compliance by leprosy out-patients and its monitoring under field condition.
    Kumar A
    Indian J Lepr; 1984; 56(2):313-8. PubMed ID: 6548501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irregularity of Dapsone intake in infectious leprosy patients attending an urban treatment centre--its magnitude and causes.
    Naik SS
    Lepr India; 1978 Jan; 50(1):45-53. PubMed ID: 651317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
    Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
    Kumar A; Balakrishnan S
    Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of medical agencies and treatment compliance by urban (Madras) leprosy patients.
    Kumar A; Sivaprasad N; Anbalagan M; Thangavel N; Durgambal K
    Lepr India; 1983 Apr; 55(2):322-32. PubMed ID: 6632787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring self administration of dapsone by patients.
    Balakrishnan S
    Lepr India; 1977 Jul; 49(3):364-71. PubMed ID: 592739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S; Nair NG
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary dapsone-resistant leprosy in San Francisco.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of long-term domiciliary dapsone (DDS) monotherapy for lepromatous leprosy in Gudiyatham Taluk, South India.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):385-6. PubMed ID: 6685703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illness and service utilization behaviours of leprosy patients.
    Kumar A; Anbalagan M
    Lepr India; 1982 Apr; 54(2):338-47. PubMed ID: 6982374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of dapsone (DDS)-resistant Mycobacterium leprae in untreated patients.
    Almeida JG; Chacko CJ; Christian M
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):374-7. PubMed ID: 6685700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone resistant leprosy, the western Kenya experience.
    Orege PA; Owili DM
    Trop Geogr Med; 1985 Jun; 37(2):139-42. PubMed ID: 4035777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone drug compliance study among leprosy patients: a comparison between qualitative and quantitative methods.
    Bhatnagar P; Kumar B; Kaur S; Kaur I; Seghal S
    Indian J Lepr; 1989 Jul; 61(3):373-8. PubMed ID: 2768885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of animal experimentation activities at the Institut Marchoux in Bamako (1982-1984)].
    Traore I; Nebout M
    Acta Leprol; 1985; 3(3):255-9. PubMed ID: 3909721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 19. Regularity of dapsone intake by leprosy patients attending urban treatment centre.
    Naik SS; Ganapati R
    Lepr India; 1977 Apr; 49(2):207-15. PubMed ID: 909287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suspicion of paucibacillary leprosy resistant to dapsone: importance of follow-up].
    Husser JA; Pattyn SR
    Acta Leprol; 1987; 5(2):147-50. PubMed ID: 3303807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.